chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chills; Muscle aches; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the arm right on 01Apr2021 at 14:30 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma which was not ongoing. The patient had cat, dog, dust and outdoor pollen allergies. Concomitant medications included fexofenadine hydrochloride (ALLEGRA) on an unknown date for allergy. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the arm right on 10Mar2021 at 14:30 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 07:00 the patient experienced chills and muscle aches. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events chills and muscle aches were recovered on an unknown date.   No follow-up attempts are needed. No further information is expected.
Patient received vaccine 8-4-18. On 8-6-18 patient called pharmacy and said shortly after vaccination had dime size area that latter grew to half dollar size area that was red and swollen, and had heat in area and pain. She also experienced pain that went down her arm. As of Monday the pain going down the arm had subsided but still had red, swollen, hot area on arm. This was her first dose of SHINGRIX. I Spoke with one employee, then transfered to another and then to another at GlaxoSmith Kline and was told that these symptoms were common. I asked if patient should receive second dose of SHINGRIX and was told cdc recommends completion of the series if reaction was Grade 1 to 3. However, if reaction was Allergic reaction then second dose contraindicated. Manufacturer recommended consulting primary care provider. I spoke with Nurse at Dr's office who said patient would need to be seen for them to determine if was allergy or not. I spoke to patient regarding all of this. Patient thought was getting better not worse and did not want to call doctor office.
Information has been received from a nurse concerning a 17 year old female with seasonal allergies and an allergy to CECLOR who on 01-APR-2008 was vaccinated IM in the left arm with 0.5 cc dose of GARDASIL (Lot # 0151X).  No concomitant medication.  Medical attention was sought through a call to the office.  Patient outcome was unknown.  No product quality complaint was involved.  Additional information has been requested. 10/08/08 This is in follow-up to report(s) previously submitted on 5/14/2008. Initial and follow up information has been received from a nurse concerning a 17 year old female with seasonal allergies and an allergy to CECLOR. On 01-APR-2008 was vaccinated IM in the left arm with a 0.5 cc dose of GARDASIL (Lot # 0151X). There was no concomitant medication. On 05-APR-2008 the patient's mother called the office reporting the patient had a headache and body aches, asking if the vaccine could be related. It was reported on the next visit that the symptoms subsided after a few days and were most likely viral in nature. On 01-JUN-2008 the patient was vaccinated with a second dose of GARDASIL without issue or complaint of symptoms. On approximately 08-APR-2008, the patient had recovered. No product quality complaint was involved. Additional information has been requested.
Watery secretion from that eye; Left eye red; Fatigue; Headache; muscle pain; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of LACRIMATION INCREASED (Watery secretion from that eye), OCULAR HYPERAEMIA (Left eye red), FATIGUE (Fatigue), HEADACHE (Headache) and MYALGIA (muscle pain) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided.  Concomitant products included VITAMINS NOS for an unknown indication.   On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-May-2021, the patient experienced LACRIMATION INCREASED (Watery secretion from that eye), OCULAR HYPERAEMIA (Left eye red), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (muscle pain) and ARTHRALGIA (Joint pain). At the time of the report, LACRIMATION INCREASED (Watery secretion from that eye), OCULAR HYPERAEMIA (Left eye red), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (muscle pain) and ARTHRALGIA (Joint pain) had resolved.            Action taken with mRNA-1273 in response to the event was not applicable.  Concomitant medications taken were antioxidants( blueberry and Lutein).  Treatment medications were not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Follow up received on 14-JUN-2021. Patient 2nd dose and event outcome was updated.
The day following the first shot, I began having chills. With the chills, came a low-grade fever. After about an hour or so, I had immense body aches. My bones felt like glass. This lasted for three and a half days.
Localized pain, muscle weakness, tiredness, sleepiness, severe vomiting, dizziness, nausea, abdominal pain, and difficulty thinking / making decisions.
LEAK OF PRODUCT FROM NEEDLE; PARTIAL ADMINISTRATION OF THE VACCINE; LEAKING OF THE PRODUCT FROM THE NEEDLE AND THE PATIENT ARM; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included unknown. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 23-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 23-MAR-2021, the subject experienced leak of product from needle. On 23-MAR-2021, the subject experienced partial administration of the vaccine. On 23-MAR-2021, the subject experienced leaking of the product from the needle and the subject arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the partial administration of the vaccine, leak of product from needle and leaking of the product from the needle and the patient arm was not reported. The case is associated with Product Quality Complaint number 90000174117 This report was non-serious. The suspected product quality complaint has been confirmed to be voided (does not meet PQC criteria) based on the PQC evaluation/investigation performed.
This case was reported by a physician and described the occurrence of inappropriate age at vaccine administration in a 4-month-old male patient who received KINRIX (batch number 5412R, expiry date 23rd July 2016). Previously administered products included DTAAP vaccine (dose 1). On an unknown date, the patient received KINRIX .5 ml, On an unknown date, an unknown time after receiving KINRIX, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown. Additional information received: 4 month old was accidentally given KINRIX as the 2nd DTAP dose.
Around 4:00am the morning after receiving the vaccine, I had a terrible headache, chills and nausea. I was unable to take anything for the headache due to the stomach upset. Finally about noon, I was able to eat enough to take some Advil and get some relief. I had a lingering dull headache for most of the day.
Facial swelling 6hrs after H1N1 nasal mist vomiting, very tired, not eating, urticaria in face/neck/chest.
pt recv vax 30SEP97 & 27OCT97 pt devel a few skin lesion on scalp & back;
Flu vaccine received at place of employment on 10/05/2011. The following evening developed right facial numbness/weakness.  Seen 10/07/2011 in AM and diagnosed with Bells palsy.
Expired vaccine used; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 17-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   no concomitant medications are provided.
Approximately 30 minutes after my 1st dose I experienced the following symptoms: Pain in the injection site, Flu like symptoms (lasted for about 3 weeks), Sneezing, Coughing, Shortness of breath, Fatigue (Had to miss 3 days of work), Headache, and it was difficult to walk. I had to get care from my primary care physician and was advised to just have the vaccine run its course. I took Mucinex (Night and Day Time) Cold & Flu to help treat the symptoms and it did help with the symptoms. It took around 3 weeks for the symptoms mentioned to subside except for the Fatigue and Difficulty of walking.
This spontaneous report was received from a licensed practical nurse (L.P.N) via a telephone call, concerning a 5 year old male patient. No concurrent conditions or medical history were reported. On 27-APR-2015, the patient was vaccinated with an improperly stored dose of PROQUAD (Merck) (Lot # K018142 Expiration date: 10-APR-2016) (dose, frequency and anatomical location of administration were not reported). No concomitant therapies or adverse experiences were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same source. Additional information has been requested.
This spontaneous report was received from a certified medical assistant and refers to a 16 year-old patient of unknown gender. No information about the patient's medical history, concurrent conditions and concomitant medications was reported. On 21-JAN-2016, the patient was inadvertently vaccinated with a dose of PROQUAD (Merck) (dose, lot #, expiry date, route of administration and anatomical location were not reported) instead of VARIVAX (Merck). No symptoms were reported. Product quality complaint (PQC) was not involved. Additional information has been requested.
beginning day of vax given fever  ranging 100-104 until today T103.3 even w/APAP & motrin;saw MD 31AUG98 WNL; gave med dx viral illness;
Fatigue, headache, loss of appetite, fever, chills, vomiting, nausea, body aches
Approximately 20 hours after injection, I began to have chills and fatigue; by 6pm, chills/coldness seem to be strong in my feet slowly moving up my entire body; after about one hour; the chills subsided and a fever ensued ranging from 99.7 - 102.9; low grade fever remained thru the night with aching in the left leg; had some fatigue the next morning but by 1pm, was feeling much better with very little fever and a little soreness in the right arm; again around midnight, feet were extremely cold and aching (had to put on some socks in order to get to sleep). I would say the side effects lasted about 36 hours.
pt recv vax; approx about 6pm same noc, began crying, was cranky; inc T 100-105; consulted MD; advised alternating apap & advil;cool bath given;screaming; taken to er; T down at next am;
pt recv vax & became wobbly w/unsteady gait; turned very pale & eyes rolled up pt was fully conscious; no sz activity; HT 50-60; pulse very weak; pt in flat position; Epi given;
This patient contacted the Vaccine Healthcare Center network after developing intense erythema that extended from his right deltoid area to his elbow.  He had received the Anthrax vaccination 2 days prior and Pneumovax 1 days prior in his right arm.  He was evaluated by a local physician and treated with Claritin.  Two days later, he developed a sore throat, pain with swallowing, fatigue, and progressive cervical lymphadenopathy.  He returned to his physician and was diagnosed with mononucleosis.  He now reports that the erythema and swelling in his right arm have resolved.
w/in 24 hrs of inject pt devel itching, erythema; on exam of lt deltoid area; has an area 9x6 inches of erythema, induration, warmth w/central crop of vesicles; ? secondary infect;
Passed out; cardiac event; This is a spontaneous report from a contactable consumer from a Pfizer-sponsored program COVAX Support. A 72-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in left arm on 05Feb2021 15:30 (Batch/Lot Number: EL9269) as a single dose for COVID-19 immunisation. Medical history included defibrillator insertion from 2014 to an unknown date (has never had it go off), blood pressure abnormal, heart disorder, blood cholesterol increased (Lipitor indication: to lower cholesterol), and eye disorder. The patient previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/lot number: EL3246), on 15Jan2021, at 15:30 PM in the left arm, for COVID-19 immunization. Concomitant medications included acetylsalicylic acid (ASPIRIN) taken for heart from 2010 and ongoing; carvedilol taken for heart from 2014 and ongoing; ubidecarenone (CO Q 10) helps with the statin for his heart from 2014 and ongoing; atorvastatin (LIPITOR) taken to lower cholesterol from 2014 and ongoing; lisinopril taken for blood pressure from 2014 and ongoing; xantofyl (LUTEIN) taken for eye from an unspecified start date and ongoing; and warfarin taken as blood thinner from 2010 and ongoing. The patient reported that 2 hours and 15 minutes after the second dose on 05Feb2021, he passed out and his defibrillator kicked in and he had a cardiac event but was not sure what kind of cardiac event. He stated it was probably unrelated, but the doctor said to call Pfizer to notify. He said he has had the defibrillator since 2014 and has never had it go off. He is having a stress test to check it all out. He added he felt great by about two hours after the defibrillator kicked in and went golfing. The outcome of the events was recovered on 05Feb2021.
Immediately after injection, patient eyes rolls, fainted, unresponsive for a short while. Attempted by caller her name, help her to exam table, head raised - observed x 30 minutes.
Post vax, the pt experienced arthralgias, achiness, and right hand spasms. No treatment was given.
Fatigue, chills, body aches, starting at 3:00 am,  lasting all day. Cleared up by the following day. No fever, didn't take anything for it. Didn't feel like eating or drinking anything, and my mouth got VERY dry. Had to force myself to sip water, but not enough. Dozed a lot throughout the day. Also had a sore arm, and the injection site turned black and blue, just like the first shot. But my arm was sore for about 4-5 days from the first shot, only2 days from this 2nd shot.
Evening of Vaccination soreness to touch at vax site. No new symptoms day after. 2 days after (chills, fever, body aches) Took Naproxen to help with body aches. 3 days after (swollen tonsils/canker sores on tonsils, profuse sweating) Took naproxen for tonsil pain and had a negative strep test and negative COVID test. 4 days after (hives appeared on hands and mild tingling in the finger tips). 5 Days after (hypersensitivity in finger tips, Hives became very itchy and painful) Took Benadryl and used ice packs on the hands, only ice helped.  6-7 days after (hives became more manageable, finger tips lost feeling and developed thick calluses, tonsil pain returned) salt gargle and numbing throat spray used. Lack of feeling in fingertips and severe pain from tonsil canker sore continue through today (9/16). I visited Primary Health on 9/11. Hives/other hand issues occurred 9/12 and doctor was not visited for those events.
Dermatitis, hives, swelling, and pruritus extending distal to injection site. Area ~ 4 inches long and ~4 inches wide.
Gave pt 2nd dose of rotavirus today before mom explained baby had already had immunizations today. Only told me when I saw marks on legs. Mom and I had previously communicated in English and she seemed to understand and responded with appropriate answers. I did ask all screening questions beforehand-mom did not tell me child had already had immunizations today. Mom, speaks Nepali. Computers were not behaving!
Sore arm; Runny nose; Chills; Headache; A report was received from a consumer concerning a 77-year old, female patient who was participating in the mRNA-1273 Emergency Use Program and developed chills, headache, runny nose, and sore arm.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 26 Dec 2020, approximately one day prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number 037K2014) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 27 Dec 2020, the patient woke up with a headache, chills, runny nose and a sore arm. Treatment for the event included Allegra, after which the patient reported her symptoms improving.   Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the events, chills, headache, runny nose, and sore arm, were not reported.; Reporter's Comments: This case concerns a 77-year old female patient, who experienced unexpected non-serious events of Rhinorrhoea and Pain in extremity, and expected non-serious events of Chills and Headache. The events occurred approximately one day after receiving their first of two planned doses of mRNA-1273 (Lot # 037K2014). Treatment for the event included Allegra. Based on temporal association between the use of the product and the onset of the events, a causal relationship cannot be excluded and the events are considered possibly related to the vaccine.
On 4/16/2021 pt complained of dyspnea with back pain and left side wrapping into chest. Pt admitted with pulmonary embolism.
SWOLLEN SITE AT INJECTION/SWOLLEN AREA AT THE INJECTION SITE; This spontaneous report received from a patient concerned a 24 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 10-APR-2021, the subject experienced swollen site at injection/swollen area at the injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from swollen site at injection/swollen area at the injection site. This report was non-serious.
Significant left-arm pain, fatigue, general muscle ache, nausea, headache, chills Began 12 hours after vaccination Symptoms still present, but beginning to improve  after 48 hours
headaches; This is a spontaneous report from a contactable consumer (patient). A 45-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on the left arm on 14Jan2021 at single dose for COVID-19 immunisation. Medical history and concomitant medications both reported as none. The patient had no recent other vaccinations. The patient experienced headaches on 15Jan2021. She said she got the vaccine last Thursday (14Jan2021) and started having a really bad headache the next day on Friday (15Jan2021), and the headache was still there, it was not going away, nothing helps. She said she was wondering if she got that from the vaccine. She also explained that her appointment with her healthcare professional (HCP) is next Friday, and asked how to manage her symptom in the meantime. No treatment received for the event. She said that the headache had not worsened or improved, it stayed the same. The outcome of the event was not recovered.  Information on the lot/batch number has been requested.
This spontaneous report was received from registered nurse, concerning a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies were not provided. On 07-MAR-2014, the patient was vaccinated with a dose of LIQUID PEDVAXHIB, 0.5 ml intramuscularly, (lot number and expiration date were not provided), which was exposed to a temperature of 47F for 10 minutes. No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
Systemic: Lymph Node Swelling-Medium, Additional Details: Pt developed lymph node swelling under shoulder on same side as vaccine (left).  pt has discussed with dr and dr is monitoring
This spontaneous report has been received from a medical assistant and refers to a patient of an unknown age and gender. The patient's medical history, concurrent conditions, drug allergies/reactions, and concomitant therapies were not reported. On 28-JUN-2017, the patient was inadvertently vaccinated with an expired dose of VARVAX, lot # L017144, expiration date 13-MAY-2017 (dose, route of administration, and frequency were not reported) for prophylaxis. On an unspecified date, the patient was vaccinated with an improperly stored dose of VARVAX (dose, route of administration, frequency, and lot #  were not reported) [it was not further specified if the expired dose of VARIVAX, was also the improperly stored dose of VARVAX]. No adverse effects were reported. No additional information was provided. Additional information was requested.
I had adverse reactions to both the  1st and 2nd vaccines  March 9 - 1st  vaccine  - 6 hours after shot I  awoke  with intense itching that lasted 3 hours -  7 days later on March 16, at 6:30 PM I  was overcome with intense  head -to-toe itching  AND  a belt of welts  circling my waistline; the welts were at least 1.2 inch in height and were litterally like  a chain of welts - the Welts and  intense all-over body itiching lasted  more than 6 hours - I took over-the-counter  antihistimines - 6 hours later the itching  subsided MARCH 30, 2021 2ND  VACCINE -  experienced intense  all over body itching  that also lasted  six hours - I  took over-the-counter antihistamines that did help ease the itching - March 31, 2021, I lost energy and have been extremely fatigued since the second vaccine. - so  fatigued that I have spent many days  bed-ridden and have been unable to household chores  - even washing  dishing from daily meals. - I am normally  high energy. I've felt so  fatigued with so littel energy I  started to wonder if I might be dying - loss of life force !
c/o h/a, stiff neck, nausea, hand & forearm swollen & discolored the noc of inject & the next day; mom reported that h/a & swelling last about 1 wk; otherwise everything was fine;